BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9229158)

  • 1. Pulmonary fungal infections in immunocompromised children.
    Shenep JL; Flynn PM
    Curr Opin Pediatr; 1997 Jun; 9(3):213-8. PubMed ID: 9229158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
    Walsh TJ; Lee JW; Roilides E; Pizzo PA
    Curr Opin Oncol; 1992 Aug; 4(4):647-55. PubMed ID: 1511021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic fungal pneumonia.
    Connolly JE; McAdams HP; Erasmus JJ; Rosado-de-Christenson ML
    J Thorac Imaging; 1999 Jan; 14(1):51-62. PubMed ID: 9894953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients.
    Walsh TJ; De Pauw B; Anaissie E; Martino P
    J Med Vet Mycol; 1994; 32 Suppl 1():33-51. PubMed ID: 7722797
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pulmonary mucormycosis in two pediatric hematopoietic stem cell transplant patients.
    Elgarten CW; Levy EM; Mattei P; Fisher BT; Olson TS; Freedman JL
    Pediatr Transplant; 2018 Nov; 22(7):e13270. PubMed ID: 30014584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in epidemiology of opportunistic infections due to Candida].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal prophylaxis in lung transplantation.
    Neoh CF; Snell G; Levvey B; Morrissey CO; Stewart K; Kong DC
    Int J Antimicrob Agents; 2014 Sep; 44(3):194-202. PubMed ID: 25123811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis in lung transplantation.
    Avery RK
    Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in immunocompromised patients.
    Sganga G
    Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
    [No Abstract]   [Full Text] [Related]  

  • 12. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia.
    Matt P; Bernet F; Habicht J; Gambazzi F; Gratwohl A; Zerkowski HR; Tamm M
    Chest; 2004 Dec; 126(6):1783-8. PubMed ID: 15596674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical approach and management for selected fungal infections in pulmonary and critical care patients.
    Limper AH
    Chest; 2014 Dec; 146(6):1658-1666. PubMed ID: 25451352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly high-dose liposomal amphotericin B for secondary prophylaxis of invasive fungal disease in immunocompromised children: experience from a pediatric case series.
    Ginocchio F; Faraci M; Fioredda F; Moroni C; Caviglia I; Barabino P; Haupt R; Castagnola E
    J Chemother; 2012 Aug; 24(4):243-4. PubMed ID: 23040693
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal infections in patients with cancer.
    Anaissie EJ; Bodey GP
    Pharmacotherapy; 1990; 10(6 ( Pt 3)):164S-169S. PubMed ID: 2075117
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi.
    Castón JJ; Linares MJ; Gallego C; Rivero A; Font P; Solís F; Casal M; Torre-Cisneros J
    Chest; 2007 Jan; 131(1):230-6. PubMed ID: 17218581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.